Athenex Announces Positive Topline Results from Two Phase III Studies of KX2-391 Ointment 1% Featured in Late Breaker Program at the 2019 American Academy of Dermatology Annual Meeting March 4, 2019 - NASDAQ Companies 0 » View More News for March 04, 2019